www.quickmedtech.com
Quick-Med Technologies is a life sciences company focused on developing broad-based technologies in the medical, consumer, healthcare and industrial markets.
Quick-Med Technologies Granted Fourth Patent For NIMBUS Products
Florida-based life sciences company Quick-Med Technologies (OTCBB:QMDT) has said today that the U.S. patent office has granted the company another patent for the process associated with its NIMBUS technology used to treat wounds.
NIMBUS is a wound dressing with non-leaching antimicrobial and is non-toxic. The dressings serve as a barrier to infection, killing germs absorbed into the dressing, while not interfering with tissue healing.
The patent, which is the fourth patent secured by Quick-Med for its NIMBUS technology, protects the process used to bind the active agent to wound dressings and other substrates, said the company.
The other three patents cover applications to a broad range of substrates including textiles, medical products, filters, and packaging composed by cellulosics.
Quick-Med Technologies is focused on developing proprietary, broad-based technologies for infection prevention and control in the consumer and healthcare markets.
The company commercialized its NIMBUS technology in traditional wound care products in 2009 and is now developing NIMBUS applications in several advanced wound dressing formats including adhesives, foams, hydrogels, films, and hydrocolloids.



















